Table 2.
Combined comprehensive diagnostic results of final clinical outcome, laboratory examination, pathological, ROSE, and mNGS.
| Diagnostic results | Patients (n = 69) |
|---|---|
| Pseudomonas aeruginosa pneumonia | 12 (17.39) |
| Klebsiella pneumoniae pneumonia | 12 (17.39) |
| Acinetobacter baumannii pneumonia | 9 (13.04) |
| Secondary organizing pneumonia | 9 (13.04) |
| Adenoviral pneumonia | 6 (8.70) |
| Enterococcus faecium pneumonia | 4 (5.80) |
| Mycoplasma pneumoniae pneumonia | 3 (4.35) |
| Tuberculosis | 3 (4.35) |
| Haemophilus influenzae pneumonia | 3 (4.35) |
| Staphylococcus aureus pneumonia | 2 (2.90) |
| Pasteurella pneumonia | 1 (1.45) |
| Pulmonary nocardiosis | 1 (1.45) |
| Human mastadenovirus pneumonia | 1 (1.45) |
| Acute fibrogenic organizing pneumonia | 1 (1.45) |
| Acute interstitial pneumonia | 1 (1.45) |
| Unable to diagnose | 1 (1.45) |
Numbers of patients are shown as n (%);
ROSE, rapid on-site evaluation of cytology; mNGS, metagenomic next-generation sequencing.